Literature DB >> 9286232

Medical problems occurring after orthotopic liver transplantation.

K L Carson1, C M Hunt.   

Abstract

Liver transplantation is complicated by specific medical problems. Diabetes mellitus occurs in 4-20% of patients undergoing liver transplantation. Patients with primary sclerosing cholangitis and ulcerative colitis experience up to a 13% incidence of colon cancer after transplantation. Lymphomas occur in 1-3% of patients after transplantation and account for 57% of malignancies occurring in adult patients. Atraumatic bone fractures occur in 22-38% of patients and neurological complications, including seizures, headache, and neuropathy occur in 19-47% of patients following liver transplantation. Patients undergoing liver transplantation may experience recurrence of their primary liver disease: hepatitis B, hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, or primary sclerosing cholangitis. In patients not receiving immunoprophylaxis after transplantation for chronic hepatitis B, recurrent hepatitis B is seen in up to 90% of patients. This can be markedly reduced with hyperimmune globulin immunoprophylaxis. Recurrent hepatitis C is seen in the majority of patients; current treatment modalities are inadequate. Recurrence of primary biliary cirrhosis or primary sclerosing cholangitis in the allograft is infrequent. Autoimmune hepatitis may recur in up to 26% of patients following liver transplantation. Primary disease recurrence in the allograft and preventive strategies are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9286232     DOI: 10.1023/a:1018853213442

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Bone disease after liver transplantation.

Authors:  J C Arnold; D Hauser; R Ziegler; B Kommerell; G Otto; L Theilmann; C Wüster
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Posttransplantation de novo tumors in liver allograft recipients.

Authors:  I Penn
Journal:  Liver Transpl Surg       Date:  1996-01

Review 3.  Recurrence of viral hepatitis after liver transplantation: insights into management.

Authors:  F G Villamil; J M Vierling
Journal:  Liver Transpl Surg       Date:  1995-09

4.  Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

Authors:  R M Jindal; I Popescu; M E Schwartz; S Emre; P Boccagni; C M Miller
Journal:  Transplantation       Date:  1994-08-15       Impact factor: 4.939

Review 5.  Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.

Authors:  V K Rustgi
Journal:  Liver Transpl Surg       Date:  1995-09

6.  Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

Authors:  V J Canzanello; L Schwartz; S J Taler; S C Textor; R H Wiesner; M K Porayko; R A Krom
Journal:  Liver Transpl Surg       Date:  1997-01

Review 7.  Neurologic complications of orthotopic liver transplantation.

Authors:  D J Bronster; S Emre; E Mor; P Sheiner; C M Miller; M E Schwartz
Journal:  Mt Sinai J Med       Date:  1994-01

8.  Employment after liver transplantation.

Authors:  P C Adams; C N Ghent; D R Grant; W J Wall
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 9.  Psychiatric aspects of organ transplantation.

Authors:  O S Surman
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

Review 10.  Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management.

Authors:  N Singh; V L Yu; T Gayowski
Journal:  Medicine (Baltimore)       Date:  1994-03       Impact factor: 1.889

View more
  1 in total

Review 1.  Male hypogonadism in cirrhosis and after liver transplantation.

Authors:  C Foresta; M Schipilliti; F A Ciarleglio; A Lenzi; D D'Amico
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.